Tag: GLP-1 receptor agonists

Ozempic-Style Obesity Drug Bypasses Neurons, Avoids Nausea and Vomiting Side Effects Most weight loss and diabetes drugs on the market struggle to deliver lasting results. GLP-1 receptor agonists, a class of drugs including semaglutide (marketed as Ozempic), have shown great promise in tackling obesity and diabetes. However, these drugs often come with unpleasant side effects […]